Abstract
Background: Genomic epidemiology has helped reconstruct the global and regional movement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is still a lack of understanding of SARS-CoV-2 spread in some of the worlds least developed countries (LDCs). Methods: To begin to address this disparity, we studied the transmission dynamics of the virus in Bangladesh during the countrys first COVID-19 wave by analysing case reports and whole-genome sequences from all eight divisions of the country. Results: We detected >50 virus introductions to the country during the period, including during a period of national lockdown. Additionally, through discrete phylogeographic analyses, we identified that geographical distance and population -density and/or -size influenced virus spatial dispersal in Bangladesh. Conclusions: Overall, this study expands our knowledge of SARS-CoV-2 genomic epidemiology in Bangladesh, shedding light on crucial transmission characteristics within the country, while also acknowledging resemblances and differences to patterns observed in other nations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
L.C. is supported by a Biotechnology and Biological Sciences Research Council (BBSRC) London Interdisciplinary Biosciences Consortium (LIDo) studentship [grant number BB/T008709/1]. S.C.H. is supported by a Sir Henry Wellcome Postdoctoral Fellowship from the Wellcome Trust [220414/Z/20/Z] (https://wellcome.org/). J.R., M.H. and G.F. are supported by the UKRI GCRF One Health Poultry Hub (Grant No. BB/S011269/1), one of twelve interdisciplinary research hubs funded under the UK governments Grand Challenge Research Fund Interdisciplinary Research Hub initiative. G.F. was supported by the French National Research Agency and the French Ministry of Higher Education and Research. M.A.S. is supported by Zoonosis and Transboundary Animal Diseases Prevention and Control project [Grant No.223038200], MoFL, Bangladesh. S.I., R.B., and M.S.S. are supported by the Combating the threats of antimicrobial resistance and zoonotic diseases to achieve the GHSA in Bangladesh [Grant no. NU2GGH002077].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was carried out under the ethical approval from the ethical approval committee of Bangladesh Livestock Research Institute, Bangladesh with the reference number BLRI/EA/2020102/2022, and with informed consent from tested individuals.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The manuscript has been revised to correct a small number of colour errors that were introduced during the PDF converting process. This has been corrected in the revision.
Data Availability
The datasets and BEAST XML files supporting the conclusions of this article are available in the Github repository. The dataset for the newly reported genetic sequence data supporting the conclusions of this article are available in GISAID EpiFlu database (https://gisaid.org) under the accession numbers included within the additional files of this article [Table S6].